lymph node metastases (C77.0) Codes C78 Secondary malignant neoplasm of respiratory and digestive organs C78.0 Secondary malignant neoplasm of lung
Malignant | Secondary or Metastatic | |
---|---|---|
Lung | C34.9 | C78.0 |
One study found that depending on the stage of the metastases (spread) the average survival time following diagnosis of metastatic lung cancer ranged from 6.3 months to 11.4 months. There are a number of factors that can impact life expectancy with metastatic lung cancer. Factors associated with a less favorable outcome include:
Nonmalignant neoplasms of the lung are classified to code 212.3 for benign, 235.7 for uncertain behavior, and 239.1 for unspecified nature. If the lung cancer is considered a metastatic site—the cancer spread from another organ to the lung—code 197.0 is assigned.
If the site of the primary cancer is not documented, the coder will assign a code for the metastasis first, followed by C80. 1 malignant (primary) neoplasm, unspecified. For example, if the patient was being treated for metastatic bone cancer, but the primary malignancy site is not documented, assign C79. 51, C80.
Metastatic tumors in the lungs are cancers that developed at other places in the body (or other parts of the lungs). They then spread through the bloodstream or lymphatic system to the lungs. It is different than lung cancer that starts in the lungs. Nearly any cancer can spread to the lungs.
C34. 90 - Malignant neoplasm of unspecified part of unspecified bronchus or lung | ICD-10-CM.
Metastatic cancer has the same name as the primary cancer. For example, breast cancer that spreads to the lung is called metastatic breast cancer, not lung cancer. It is treated as stage IV breast cancer, not as lung cancer.
(meh-TAS-tuh-sis) The spread of cancer cells from the place where they first formed to another part of the body. In metastasis, cancer cells break away from the original (primary) tumor, travel through the blood or lymph system, and form a new tumor in other organs or tissues of the body.
But almost always, stage III cancer is in just one lung. It's also limited to the lymph nodes, organs, and other tissue near that organ. The cancer has not spread, or metastasized, beyond that. That's why this stage is also called locally advanced or locoregional disease.
Stage 4 is advanced lung cancer and is metastatic—meaning the cancer has spread from the lung, where it originated, into other parts of the body. Metastasis occurs when cancer cells separate from the original tumor and move through the body via the blood or lymph system.
Metastatic spread The pulmonary arteries are the most common route for metastases. Cancers most likely to metastasize to the lungs include those with a rich vascular supply draining directly into the systemic venous system. Spread via bronchial arteries may be responsible for some endobronchial metastases.
ICD-10 Code for Malignant neoplasm of unspecified part of right bronchus or lung- C34. 91- Codify by AAPC.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code C34. 90 for Malignant neoplasm of unspecified part of unspecified bronchus or lung is a medical classification as listed by WHO under the range - Malignant neoplasms .
Cancer of the lung, squamous cell, stage 1. Cancer of the lung, squamous cell, stage 2. Cancer of the lung, squamous cell, stage 3. Cancer of the lung, squamous cell, stage 4. Cancer, lung, non small cell. Eaton-lambert syndrome due to small cell carcinoma of lung. Eaton-lambert syndrome due to small cell lung cancer.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Functional activity. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology]
In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
Lymphangitic carcinomatosis: A condition in which cancer cells spread from the original (primary) tumor and invade lymph vessels (thin tubes that carry lymph and white blood cells through the body’s lymph system). The invaded lymph vessels then fill up with cancer cells and become blocked.
Although lymphangitic carcinomatosis can occur anywhere in the body, it commonly happens in the lungs. It can happen in many types of cancer but is most common in breast, lung, colon, stomach, pancreatic, and prostate cancer. Also called carcinomatous lymphangitis.
Since it is of the lymphatics, and not the lung proper, I would assign C77.1, secondary and unspecified malignant neoplasm of intrathoracic lymph nodes for the lymphangitic carcinomatosis of the lung.